Based in Ohio, NAMSA  is the only full continuum Contract Research Organization in the world focused exclusively on medical devices.

NAMSA was the first independent company world wide to focus solely on testing medical device materials for safety.

NAMSA’s suite of services are designed to lower development costs and accelerate regulatory approval and commercialization globally for medical device and in vitro diagnostics (IVD) technologies.

NAMSA offers expert medical device testing, regulatory, reimbursement and quality consulting services, and clinical research support to aid clients at every stage in the medical device development continuum.

www.namsa.com

INVESTMENT DATE 
2020

SECTOR
Medtech

TRANSACTION TYPE 
Buy-Out

GROWTH THEME 
Product Development / Internationalization

LOCATION
United States